MedTrace Logo

OneTouch® Verio™Pro+ Blood Glucose Monitoring System Clinical Accuracy Study in China

NCT01795625 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 301

Last updated 2023-08-21

No results posted yet for this study

Summary

The evaluation will determine professional clinical accuracy comparing the OneTouch® Verio™Pro+ blood glucose results with the YSI 2300 analyzer. "Professional Clinical Accuracy" is defined as accuracy of the system when used by a trained healthcare professional.

Conditions

  • Blood Glucose Measurement

Sponsors & Collaborators

  • Johnson & Johnson Medical, China

    lead INDUSTRY

Principal Investigators

  • Yongde Peng, Professor · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

  • Fengling Chen, Professor · Shanghai Jiaotong University, medical school affiliated Third People's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01795625 on ClinicalTrials.gov